返回
T
Ting Ma
yunnan normal university
21H指数
81论文数
1.3K被引数
收录论文 29
发表时间
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER)疗效、安全性及生物标志物:新辅助达比奇利布(CDK4/6抑制剂)联合芳香化酶抑制剂在可手术HER2阴性腔B型乳腺癌中的应用——一项前瞻性、单中心、单臂、II期试验(DANCER)
MedComm
IF10.7

